French Validation of the CAPTURE Case Finding Tool for Obstructive Respiratory Disease
NCT ID: NCT05654597
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
1002 participants
OBSERVATIONAL
2023-04-01
2025-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 2)
NCT03653611
Assessing Functional Capacity in Directly and Remotely Monitored Home-based Settings: A Protocol for a Multinational Validation Study in Individuals With Chronic Respiratory Diseases
NCT06447831
Evaluation of the Reversibility of the Bronchial Obstruction by Impulse Oscillometry Technique in Chronic Obstructive Pulmonary Disease (COPD): Correlation With Functional Features Measured by Plethysmography and Dyspnoea
NCT02928744
Long-term Effects of Non-invasive Ventilation in Hypercapnic Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01592656
Zephyr Etude Post-Inscription (French Registry)
NCT04517916
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants willing to participate will have a short interview, and then will have to answer the 5-item CAPTURE questionnaire. They will be assisted to perform a peak expiratory flow measurement with a portable device. The comparison will be made between the CAPTURE decision and a portable spirometry assessing the presence or not of an obstructive disorder.
Patient screened either by the tool or the spirometry will be addressed to a doctor. Follow-up at 6 months will be set up in order to assess the entry or not of those patients to an approved health care pathway.
At the end of each center's participation, a questionnaire will be sent to all healthcare professionals working on the study, to assess the ease of use of spirometry and the CAPTURE tool and its possible implementation in clinical practice.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants aged 40 or more, without diagnosis of COPD or asthma
Men and women attending aged 40 or more, without previous diagnosis of chronic obstructive pulmonary disease or asthma.
CAPTURE tool
CAPTURE 5-item questionnaire and a selected use of peak expiratory flow measurement.
Spirometry
Spirometry performed with a portable device, used for comparison with the CAPTURE tool.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CAPTURE tool
CAPTURE 5-item questionnaire and a selected use of peak expiratory flow measurement.
Spirometry
Spirometry performed with a portable device, used for comparison with the CAPTURE tool.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Provision of dated and signed informed consent form,
* Currently being treated by a healthcare professional,
* Patients affiliated to the french social security system.
Exclusion Criteria
* Patients with any condition making them unable to perform spirometry or answer a short questionnaire,
* Patients unable to give free and informed consent.
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Groupe Hospitalier du Havre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Groupe Hospitalier du Havre
Le Havre, Normandy, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A00209-34
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.